PERSKY MARLA

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 38% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
PERSKY MARLA's trades of Xeris Biopharma Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
274.02
Quantity 82,086
Value US$3,974,651
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-03
PlS Planned sale
71,434 -25.5%
22.03
US$1,534,247 		71,434 -25.5% 22.03 US$1,534,247
2026-06-03 2026-06-03
PrS Proposed sale
82,086
274.02
US$3,974,651 		82,086 274.02 US$3,974,651
2025-09-12 2025-09-11
PlS Planned sale
47,684 +26.4%
489.57
US$3,298,318 		47,684 +26.4% 489.57 US$3,298,318
2025-09-11 2025-09-11
PrS Proposed sale
15,500
7.81
US$121,055 		15,500 7.81 US$121,055
2023-11-15 2023-11-14
B Purchase
6,370 +inf%
1.58
US$10,058 		6,370 +inf% 1.58 US$10,058